The tumour vasculature often contains high levels of ED‐B, and shows increased permeability and a higher interstitial fluid pressure compared with normal blood vessels, thus forming a major barrier to the uptake of therapeutic agents (Menrad and Menssen, 2005). This evidence concerns the gene FN1 and neoplasm.